Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paediatric Hepatic International Tumour Trial
2016-002828-85Phase 3Unknown
- Sponsor
- University of Birmingham
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cisplatin in hepatoblastoma and hepatocellular carcinoma (HCC) (2 arms), sponsored by University of Birmingham. Primary endpoint: Event-Free Survival. Status: unknown.
02
Drugs
cisplatin
03
Conditions
hepatoblastomahepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2016-002828-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002828-85.